Are Pharma Stocks the Next Growth Story?

April 24 (Bloomberg) -- Bloomberg's Jonathan Ferro reports that low patent expirations may clear the obstacles to growth for pharma stocks. He speaks on Bloomberg Television's "Countdown." (Source: Bloomberg)

Most Recent Videos

After 1929 Crash Rates Stayed Low for Decades: Zentner
48:41 - Jan. 29 -- Morgan Stanley’s Ellen Zentner discusses Fed policy, bonds and the economy. She speaks on “Bloomberg Surveillance.”
  • Has the Fed Boxed Themselves Into a Corner?
  • U.S. Child Poverty Bests Only Romania in OECD Ranks
  • I’d Rather Fed Wait on Rate Increase: Zentner